The anti-tumor effect of gemcitabine on gallbladder carcinomas can be enhanced by suppressing the NF-κB pathway (Yang et al., 2012), which suggests that oxymatrine may increase efficacy of chemotherapeutic drugs by down-regulating the NF-κB pathway. The gene discussed is NFKB1; the disease is neoplasm.